CereVasc, Inc. announced it has received its second FDA Breakthrough Device designation for the investigational eShunt system ...

Vivasure Medical, an Ireland-based developer of fully absorbable technology for percutaneous vessel closure, announced ...

R3 Vascular Inc. announced that the first patient was enrolled in the company’s ELITE-BTK pivotal trial evaluating its Magn ...

Surmodics, Inc. announced the publication of results from the TRANSCEND clinical trial. The global randomized study demonstrat ...

IceCure Medical Ltd. announced findings from three investigator-initiated studies of the company’s ProSense system for the ...

Venova Medical announced the completion of patient enrollment for the company’s VENOS-2 early feasibility study. Accordi ...

With a focus on endovascular aneurysm repair (EVAR) for abdominal aortic aneurysms (AAAs) and thoracoabdominal aortic aneurysms ( ...

Anaconda Biomed, SL, announced the publication of results of the ANAIS study, which evaluated the safety and performance of the c ...

Imperative Care, Inc. announced it will fund an investigator-initiated, multicenter, randomized controlled clinical trial compari ...

April 15, 2025—enVVeno Medical Corporation recently announced the presentation of findings from a subanalysis of the 1-year data from the prospe ...

Terumo Neuro, a wholly owned subsidiary of Terumo Corporation, announced that the company’s dual-layer micromesh carotid st ...

Delcath Systems, Inc., an interventional oncology company focused on the treatment of primary and metastatic liver cancers, annou ...